BioSTL fosters collaborative efforts and builds regional infrastructure to achieve St. Louis’ potential in biosciences. BioSTL issued the following News Update on August 27, 2012.
MediBeacon LLC, a new St. Louis-based optical diagnostic company has announced its initial round of funding.
BioSTL’s affiliate, the BioGenerator, provided business assistance and funding to MediBeacon through its i6 Challenge program that supports the launch of local bioscience startups. MediBeacon also received funding from St. Louis Development Corporation and Missouri Technology Corporation.
MediBeacon will utilize the shared laboratory facilities of the BioGenerator Accelerator Labs, and will have offices at the Center for Emerging Technologies.
Please see the attached press release from MediBeacon and coverage in the attached article from last week’s St. Louis Business Journal.